VLK, GST étiqueté humain, recombinant, exprimé en cellules du baculovirus infectées par le Sf9, > = 70 % (SDS-PAGE), solution aqueuse tamponnée de glycérol

Code: srp5369-20ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

VLK or vertebrate lonesome kinase is a protein kinase which is first expressed in E-cadherin-positive anterior visceral endoderm and mesendoderm, and late...


en savoir plus

Votre prix
$356.32 20UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

VLK or vertebrate lonesome kinase is a protein kinase which is first expressed in E-cadherin-positive anterior visceral endoderm and mesendoderm, and later its expression is confined to E-cadherin-negative mesenchyme. VLK regulates the rate of protein export from the Golgi and thereby plays an important role in the formation of functional stroma by mesenchymal cells. Targeted disruption of VLK leads to a defect in lung development and delayed ossification of endochondral bone. VLK deficient mice display neonatal lethality due to respiratory failure, with a suckling defect arising from a cleft palate. VLK is required for the appropriate timing of flat proliferative chondrocyte differentiation.

Physical form

Supplied in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, 25% glycerol.

Preparation Note

After opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles.

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... PKDCC(91461)
mol wt~69 kDa
NCBI accession no.NM_138370
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
storage temp.−70°C
Ce produit répond aux critères suivants: